Clinical Trial Update: Study of Triamcinolone Acetonide on the Growth Velocity of Children, Ages 3 to 9, With Perennial Allergic Rhinitis (PAR) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the effect of Triamcinolone Acetonide on growth velocity in children aged 3 to 9 with perennial allergic rhinitis; results wer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis

Drugs mentioned

• TRIAMCINOLONE ACETONIDE (TRIAMCINOLONE ACETONIDE)

Snippet

Sponsor: Sanofi | Conditions: Rhinitis, Allergic, Perennial | Phase 4 | Status: COMPLETED | Results posted: 2012-08-07